These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 11255932
1. Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Hölter SM, Henniger MS, Lipkowski AW, Spanagel R. Psychopharmacology (Berl); 2000 Dec; 153(1):93-102. PubMed ID: 11255932 [Abstract] [Full Text] [Related]
2. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Walker BM, Koob GF. Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837 [Abstract] [Full Text] [Related]
3. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Hölter SM, Spanagel R. Psychopharmacology (Berl); 1999 Aug; 145(4):360-9. PubMed ID: 10460312 [Abstract] [Full Text] [Related]
4. Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice. Zhou Y, Kreek MJ. Brain Res; 2019 Dec 01; 1724():146410. PubMed ID: 31469985 [Abstract] [Full Text] [Related]
5. The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats. Uhari-Väänänen J, Eteläinen T, Bäckström P, Oinio V, Carroll FI, Raasmaja A, Kiianmaa K, Piepponen P. Eur Neuropsychopharmacol; 2019 Dec 01; 29(12):1386-1396. PubMed ID: 31679889 [Abstract] [Full Text] [Related]
6. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. Hölter SM, Danysz W, Spanagel R. J Pharmacol Exp Ther; 2000 Feb 01; 292(2):545-52. PubMed ID: 10640291 [Abstract] [Full Text] [Related]
7. Brief prenatal ethanol exposure alters behavioral sensitivity to the kappa opioid receptor agonist (U62,066E) and antagonist (Nor-BNI) and reduces kappa opioid receptor expression. Nizhnikov ME, Pautassi RM, Carter JM, Landin JD, Varlinskaya EI, Bordner KA, Werner DF, Spear NE. Alcohol Clin Exp Res; 2014 Jun 01; 38(6):1630-8. PubMed ID: 24796820 [Abstract] [Full Text] [Related]
8. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Lindholm S, Werme M, Brené S, Franck J. Behav Brain Res; 2001 May 01; 120(2):137-46. PubMed ID: 11182162 [Abstract] [Full Text] [Related]
9. The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats. Deehan GA, McKinzie DL, Carroll FI, McBride WJ, Rodd ZA. Pharmacol Biochem Behav; 2012 Jun 01; 101(4):581-7. PubMed ID: 22429993 [Abstract] [Full Text] [Related]
10. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists. Carey GJ, Bergman J. J Pharmacol Exp Ther; 2001 Apr 01; 297(1):215-23. PubMed ID: 11259547 [Abstract] [Full Text] [Related]
11. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Mitchell JM, Liang MT, Fields HL. Psychopharmacology (Berl); 2005 Nov 01; 182(3):384-92. PubMed ID: 16001119 [Abstract] [Full Text] [Related]